121
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

MnSOD Val16Ala gene polymorphism is associated with REDOX biomarkers in the elderly of primary health care in the city of Porto Alegre

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 293-300 | Received 04 Sep 2019, Accepted 20 Apr 2020, Published online: 05 May 2020

References

  • Harman D. The free radical theory of aging. Antioxid Redox Signal. 2003;5:557–561.
  • Hekimi S, Lapointe J, Wen Y. Taking a “good” look at free radicals in the aging process. Trends Cell Biol. 2011;21:569–576.
  • Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95.
  • Wong HS, Dighe PA, Mezera V, et al. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions. J Biol Chem. 2017;292:16804–16809.
  • Falone S, Santini S Jr., Cordone V, et al. Regular and moderate exercise counteracts the decline of antioxidant protection but not methylglyoxal-dependent glycative burden in the ovary of reproductively aging mice. Oxid Med Cell Longev. 2016;2016:3837623.
  • Kendall DM, Harmel AP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care. 2002;8:S54–S57.
  • Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–349.
  • Sutton A, Khoury H, Prip-Buus C, et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 2003;13:145–157.
  • Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A. 1996;93:4471–4473.
  • Muller GC, Gottlieb MG, Luz Correa B, et al. The inverted CD4:CD8 ratio is associated with gender-related changes in oxidative stress during aging. Cell Immunol. 2015;296:149–154.
  • Nogueira GM, Schwanke CH, Closs VE, et al. Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care. Curr Alzheimer Res. 2016;13:1056–1063.
  • Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–1313.
  • Valle Gottlieb MG, da Cruz IBM, Duarte MMF, et al. Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers. J Clin Endocrinol Metab. 2010;95:586–591.
  • Ghasemi A, Zahediasl S, Azizi F. Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem. 2010;43:89–94.
  • Gomes I, Nogueira EL, Engroff P, et al. The multidimensional study of the elderly in the family health strategy in Porto Alegre, Brazil (EMI-SUS). Pan Am J Aging Res. 2013;1:20–24.
  • Witko-Sarsat V, Friedlander MN, Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524–2532.
  • Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem. 2001;268:42–47.
  • Tatsch E, Bochi GV, Pereira R da S, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem. 2011;44:348–350.
  • Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: then FRAP assay. Anal Biochem. 1996;239:70–76.
  • Debomoy LK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19:5444.
  • Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999;59:602–606.
  • Carter JD, Madamanchi NR, Stouffer GA, et al. Ultrafine particulate matter exposure impairs vasorelaxant response in superoxide dismutase 2-deficient murine aortic rings. J Toxicol Environ Health A. 2018;81:106–115.
  • Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 2002;51:597–604.
  • Braga C. Avaliação da concentração plasmática do Produto Protéico de Oxidação Avançada (AOPP) e da Proteína C - Reativa de Alta Sensibilidade (hs – PCR) em pacientes com doença reumática valvar crônica. [dissertação]. Paraná (PR): Universidade Federal do Paraná; 2013.
  • Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
  • Pandey KB, Rizvi SI. Resveratrol May Protect Plasma Proteins from Oxidation under Conditions of Oxidative stress In Vitro. J Braz Chem Soc. 2010;21:909–913.
  • Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2007;77:188–192.
  • Čolak E, Dimitrijević-Srećković V, Stanković S, et al. Biomarkers of enzymatic and non-enzymatic antioxidative defense in type 2 diabetes mellitus - comparative analysis. Biochem Med. 2008;18:42–51.
  • Gawlik K, Naskalski JW, Fedak D, et al. Markers of antioxidant defense in patients with type 2 diabetes. Oxid Med Cell Longev. 2016;2016:6.
  • Kavitha G, Ramani G, Dhass PK, et al. Oxidative stress, interleukin (IL-6) and atherogenic index of plasma in diabetic nephropathy. Int J Appl Biol Pharm. 2011:211–216.
  • Pulido R, Jimenez-Escrig A, Orensanz L, et al. Study of plasma antioxidant status in Alzheimer’s disease. Eur J Neurol. 2005;12:531–535.
  • Pascotini ET. A função da MnSOD Ala16Val, O stress oxidativo e marcadores de apoptose como biomarcadores em pacientes com Acidente Vascular Encefálico Crônico. Anais do 13 Congresso Gaúcho de Clínica Médica. Blucher Medical Proceedings. 2016;7:77–83.
  • Indo HP, Yen HC, Nakanishi I, et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr. 2015;56:1–7.
  • Abbasi M, Daneshpour MS, Hedayati M, et al. The relationship between MnSOD Val16Ala gene polymorphism and the level of serum total antioxidant capacity with the risk of chronic kidney disease in type 2 diabetic patients: a nested case-control study in the Tehran lipid glucose study. Nutr Metab. 2018;15:25.
  • Wang P, Zhu Y, Xi S, et al. Association between MnSOD Val16Ala polymorphism and cancer risk: evidence from 33,098 cases and 37,831 controls. Dis Markers. 2018;2018:3061974.
  • Abdelrauf LM, Abdel Rahman MF, Abdel-Maksoud SM, et al. Association of manganese superoxide dismutase Ala16Val polymorphism in the incidence of acute myocardial infarction in the Egyptians. J Genet Eng Biotechnol. 2017;15:415–418.
  • Li X, Shen M, Cai H, et al. Association between manganese superoxide dismutase (MnSOD) polymorphism and prostate cancer susceptibility: a meta-analysis. Int J Biol Markers. 2016;31:e422–e430.
  • Pourvali K, Abbasi M, Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J Med Biotechnol. 2016;8:48–56.
  • Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2008;17:3298–3305.
  • Case AJ, Domann FE. Absence of manganese superoxide dismutase delays p53-induced tumor formation. Redox Biol. 2014;2:220–223.
  • Case AJ, Madsen JM, Motto DG, et al. Manganese superoxide dismutase depletion in murine hematopoietic stem cells perturbs iron homeostasis, globin switching, and epigenetic control in erythrocyte precursor cells. Free Radic Biol Med. 2013;56:17–27.
  • Cyr AR, Brown KE, McCormick ML, et al. Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. Redox Biol. 2013;1:172–177.
  • Dziedzic M, Orlowska E, Petkowicz B, et al. Levels of renalase and advanced oxidation protein products with regard to catecholamines in haemodialysed patients. Ann Agric Environ Med. 2017;24:453–458.
  • Klisic A, Isakovic A, Kocic G, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2018;126:371–378.
  • Gryszczynska B, Formanowicz D, Budzyn M, et al. Advanced oxidation protein products and carbonylated proteins as biomarkers of oxidative stress in selected atherosclerosis-mediated diseases. BioMed Res Int. 2017;2017:4975264.
  • Ungurianu A, Margină D, Grădinaru D, et al. Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease. Mol Med Rep. 2017;15:256–262.
  • Miljkovic M, Stefanovic A, Simic-Ogrizovic S, et al. Association of dyslipidemia, oxidative stress, and inflammation with redox status in VLDL, LDL, and HDL lipoproteins in patients with renal disease. Angiology. 2018;69:861–870.
  • Gradinaru D, Khaddour H, Margina D, et al. Insulin-leptin axis, cardiometabolic risk and oxidative stress in elderly with metabolic syndrome. Exp Clin Endocrinol Diabetes. 2018;126:445–452.
  • Lin L, Zhao GJ, Qin LL. Association between advanced oxidation protein products (AOPP) and vascular calcification in uremic patients. Eur Rev Med Pharmacol Sci. 2017;21:4147–4152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.